Congress: Restart cancer clinical trials in the next coronavirus relief package

Recipients

  • Your Senators
  • Your Representative

Contact

*Required fields
  Congress requires a phone number in order to submit your comments.
 
 

Message

Dear [Decision Maker],

As a constituent and a volunteer for the American Cancer Society Cancer Action Network, I am writing to urge you to include relief for the nonprofit sector in the next COVID relief package so that organizations like the American Cancer Society can continue its important work. Many charities, including the American Cancer Society, are serving people and communities in crisis, yet revenues have fallen precipitously. In addition, the impact of COVID-19 on the cancer research ecosystem is severe, and relief is needed to address both short- and long-term impacts on labs, researchers and clinical trials.



Specifically, I urge that Members of Congress extend and expand the Paycheck Protection Program by extending eligibility to all nonprofits regardless of size as well as expanding the universal charitable deduction.

I'm also asking that Congress provide at least $15.5 billion in emergency supplemental funding to the NIH to restart research and clinical trials impacted by COVID-19. Individual trial sites are struggling to safely facilitate continued care for already-enrolled patients, new enrollments are frozen, and new trials are delayed indefinitely. The most immediate effects will be felt by the patients taking part in these trials. Since clinical trials and the broader drug development process can take years or even decades to complete, this disruption on therapeutic innovation in cancer care is likely to have long-lasting effects without aggressive measures to mitigate the disruption.

Thank you for your consideration.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]